サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1360049

北米の人工心肺市場の2028年までの予測-地域別分析-：製品別、用途別、タイプ別、年齢層別、最終用途別

North America Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis - By Product, Application, Type, Age Group, and End Use
出版日: | 発行: The Insight Partners | ページ情報: 英文 144 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
北米の人工心肺市場の2028年までの予測-地域別分析-：製品別、用途別、タイプ別、年齢層別、最終用途別
出版日: 2023年07月27日
発行: The Insight Partners
ページ情報: 英文 144 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の人工心肺市場は2022年に2億6,135万米ドルと評価され、2028年には3億3,451万米ドルに達すると予測されています。2022年から2028年までのCAGRは4.2%と推定されます。

高齢化に伴う外科手術の増加が北米の人工心肺市場を活性化

外科的処置は、心血管疾患や肺疾患などの健康状態を管理するために必要です。一部の医療ケースでは、手術なしでは代替手段が効かないです。2020年に国立生物工学情報センター（NCBI）に掲載された論文によると、世界中で毎年～3億1,000万件の大手術が行われており、そのうち5,000万～6,000万件は米国で行われています。心臓血管外科手術に対する需要の高さは、高齢化社会における心臓血管疾患の発生率の増加に起因しています。さらに、肺移植は重篤な肺障害やCOVID-19に関連した呼吸不全が治癒しない患者にとって唯一の有用な治療法である可能性があります。このように、心血管系や肺移植手術の増加に伴い、この地域では心肺酸素供給装置の需要も増加傾向にあります。

WHOによると、60歳以上の高齢者の割合は2015年の12％から2050年には22％に達すると推定されています。心血管疾患は、65歳以上の成人の死因の第1位を占めています。加齢は心臓や血管に変化をもたらし、これらの疾患の発症リスクを高める。そのため、老年人口における心血管疾患の流行が、人工心肺市場の成長に寄与しています。

北米の人工心肺市場概要

北米の人工心肺市場は米国、カナダ、メキシコに区分されます。同地域では米国が最大の市場貢献者となる見込みです。北米の市場成長は、同地域における心血管疾患と呼吸器疾患の有病率の上昇に起因しています。これにより、COPD、慢性気管支炎、うっ血性心不全などの心肺疾患の発生率が増加しています。例えば、米国肺協会によると、2020年に米国で1,250万人がCOPD、慢性気管支炎、肺気腫と診断されます。さらに、このような疾患の有病率や発症率の上昇は、多くの患者集団における外科的処置の数を増加させ、心肺酸素供給器市場の成長に拍車をかけています。例えば、lifespan health systemが発表した調査によると、米国では毎年50万件の開心術が行われています。また、呼吸不全や感染症の増加により、人工心肺の需要がさらに高まると予想されています。

さらに、心血管系疾患の有病率の増加は世界レベルでの主要な死因であり、酸素吸入器は緊急時の救命に大いに役立ちます。世界保健機関（WHO）によると、年間1,790万人の命がCVDによって失われています。さらに、有利な償還政策も心肺酸素装置の成長に十分な機会をもたらすと期待されています。そのため、心肺疾患の有病率や発生率の上昇は、予測期間中の心肺酸素装置市場の成長を促進すると見られています。

北米の人工心肺市場収益と2028年までの予測（金額）

北米の人工心肺市場セグメンテーション

北米の人工心肺市場は製品、用途、タイプ、年齢層、最終用途、国別に細分化されます。製品別では、膜型酸素供給器と気泡型酸素供給器に二分されます。2022年の市場シェアは膜式酸素吸入器が大きいです。

用途別では、市場は心臓用と呼吸器用に二分されます。2022年の市場シェアは心臓用が大きいです。さらに、心臓は急性心筋梗塞、心筋炎、移植後合併症、代償性心筋症、その他に区分されます。さらに呼吸器は、呼吸不全、急性呼吸窮迫症候群、肺塞栓症、肺炎、COVID-19にセグメント化されます。

タイプ別に見ると、市場は再利用型人工心肺と使い捨て型人工心肺に二分されます。2022年の市場シェアは再利用型人工心肺が大きいです。

年齢層に基づくと、市場は成人、小児、新生児に区分されます。成人は2022年に最も大きな市場シェアを占めました。

エンドユースに基づくと、市場は病院・診療所、外来手術センター、その他に区分されます。2022年の市場シェアは病院・診療所が最大でした。

国別では、市場は米国、カナダ、メキシコに区分されます。米国が2022年の市場シェアを独占しました。

Getinge AB、LivaNova Plc、Medtronic Plc、Terumo Corp、Nipro Medical Corp、Microport Scientific Corp、Braile Biomedica Industry, Commerce and Representation Ltd、Chalice Medical Ltd、Fresenius Medical Care AG &Co KGaAが、同地域の人工心肺市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 北米における人工心肺市場の要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の人工心肺市場情勢

  • 概観
  • PEST分析
    • 北米のPEST分析

専門家の見解

第5章 北米の人工心肺市場-主要市場力学

  • 市場促進要因
    • 心肺疾患の発生率の増加
    • 高齢化に伴う外科手術の増加
  • 市場抑制要因
    • 熟練した専門家の不足
  • 市場機会
    • 小児および新生児患者における人工心肺の使用増加
  • 今後の動向
    • 肺移植術におけるポータブル体外式膜酸素化の使用
  • 影響分析

第6章 人工心肺市場-北米分析

  • 北米の人工心肺市場収益と予測分析

第7章 北米の人工心肺市場-2028年に至る収益と予測-製品別

  • 人工心肺市場の製品別収益シェア（2021年・2028年）
  • 膜式酸素供給器
  • バブル式酸素供給器

第8章 北米の人工心肺市場-用途別収益と2028年までの予測

  • 人工心肺市場の2021年および2028年タイプ別売上高シェア（%）
  • 心臓用
  • 呼吸器

第9章 北米の人工心肺市場分析と2028年までの予測-タイプ別

  • 人工心肺市場：タイプ別2021年・2028年（%）
  • 再利用型酸素供給器
  • 使い捨て酸素供給器

第10章 北米の人工心肺市場の分析と2028年までの予測：年齢層別

  • 人工心肺市場：年齢層別2021年・2028年（%）
  • 成人
  • 小児
  • 新生児

第11章 北米の人工心肺市場：エンドユース別収益と2028年までの予測

  • 人工心肺市場のエンドユース別売上高シェア（2021年・2028年）
  • 病院および診療所
  • 外来手術センター
  • その他

第12章 北米の人工心肺市場：収益と2028年までの予測：国別分析

  • 北米

第13章 北米の人工心肺市場-業界情勢

  • 人工心肺市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第14章 企業プロファイル

  • Getinge AB
  • LivaNova Plc
  • Medtronic Plc
  • Terumo Corp
  • Nipro Medical Corp
  • MicroPort Scientific Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Chalice Medical Ltd
  • Fresenius Medical Care AG & Co KGaA

第15章 付録

図表

List Of Tables

  • Table 1. United States Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 2. United States Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 3. United States Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 4. United States Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 5. United States Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 6. United States Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 7. United States Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 8. Canada Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 9. Canada Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 10. Canada Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 11. Canada Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 12. Canada Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 13. Canada Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 14. Canada Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 15. Mexico Cardiopulmonary Oxygenators Market, by Product - Revenue and forecast to 2028 (USD Million)
  • Table 16. Mexico Cardiopulmonary Oxygenators Market, by Application - Revenue and forecast to 2028 (USD Million)
  • Table 17. Mexico Cardiopulmonary Oxygenators Market, by Cardiac Application - Revenue and forecast to 2028 (USD Million)
  • Table 18. Mexico Cardiopulmonary Oxygenators Market, by Respiratory Application - Revenue and forecast to 2028 (USD Million)
  • Table 19. Mexico Cardiopulmonary Oxygenators Market, by Type - Revenue and forecast to 2028 (USD Million)
  • Table 20. Mexico Cardiopulmonary Oxygenators Market, by Age Group - Revenue and forecast to 2028 (USD Million)
  • Table 21. Mexico Cardiopulmonary Oxygenators Market, by End Use - Revenue and forecast to 2028 (USD Million)
  • Table 22. Recent Organic Growth Strategies in North America Cardiopulmonary Oxygenator Market
  • Table 23. Recent Inorganic Growth Strategies in The North America Cardiopulmonary Oxygenator Market
  • Table 24. Glossary of Terms

List Of Figures

  • Figure 1. North America Cardiopulmonary Oxygenator Market Segmentation
  • Figure 2. North America Cardiopulmonary Oxygenator Market, by Country
  • Figure 3. North America Cardiopulmonary Oxygenator Market Overview
  • Figure 4. Membrane Oxygenator Segment Held Largest Share of Product Segment in Cardiopulmonary Oxygenator Market
  • Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. North America Experts\' Opinion
  • Figure 8. North America Cardiopulmonary Oxygenators Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Cardiopulmonary Oxygenators Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 11. Membrane Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Bubble Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. North America Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
  • Figure 14. Cardiac: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Acute myocardial infarction: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Myocarditis: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Post-transplant Complication: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Decompensated Cardiomyopathy: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Respiratory: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Respiratory Failure: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Acute Respiratory Distress Syndrome: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Pulmonary Embolism: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Pneumonia: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. COVID-19: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. North America Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
  • Figure 27. Reusable Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Disposable Oxygenator: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. North America Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
  • Figure 30. Adults: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Pediatric: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Neonates: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
  • Figure 34. Hospitals and Clinics: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Ambulatory Surgical Centers: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Others: North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. North America: Cardiopulmonary Oxygenators Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 38. North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
  • Figure 39. United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 40. Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 41. Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
  • Figure 42. North America Growth Strategies in Cardiopulmonary Oxygenator Market
目次
Product Code: BMIRE00028632

The North America Cardiopulmonary Oxygenator Market was valued at US$ 261.35 million in 2022 and is expected to reach US$ 334.51 million by 2028. It is estimated to register a CAGR of 4.2% from 2022 to 2028.

Increasing Surgical Procedures with Surging in Aging Population is Fueling North America Cardiopulmonary Oxygenator Market

Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. Per an article published in the National Center for Biotechnology Information (NCBI) in 2020, ~310 million major surgical operations are carried out each year worldwide, of which 50-60 million are performed in the US. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.

According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.

North America Cardiopulmonary Oxygenator Market Overview

The cardiopulmonary oxygenators market in North America is segmented into the US, Canada, and Mexico. The US is expected to be the largest contributor to the market in this region. The market growth in North America is ascribed to the rising prevalence of cardiovascular and respiratory disorders in the region. This has increased the incidence of cardiopulmonary disorders such as COPD, chronic bronchitis, congestive heart failure, and others. For instance, as per American Lung Association, ~12.5 million people are diagnosed with COPD, chronic bronchitis, and emphysema in the US in 2020. Moreover, rising prevalence and incidences of such disorders have increased the number of surgical procedures among large patient population which has fueled the growth of cardiopulmonary oxygenator market. For instance, as per study published by lifespan health system, ~500,00 open heart surgeries are performed in the US every year. Additionally, increase in prevalence of respiratory failure and infectious diseases are further expected to create demand for cardiopulmonary oxygenator.

Furthermore, rising prevalence of cardiovascular disorders are the leading cause of death on the global level and oxygenator can be of great assistance in lifesaving in emergency cases. As per world health organization, ~17.9 million lives are lost due to CVDs annually. Moreover, favorable reimbursement policies are also expected to create ample opportunities for the growth of cardiopulmonary oxygenator. Therefore, rising prevalence and incidence of cardiopulmonary disorders are expected to drive the growth of cardiopulmonary oxygenator market during the forecast period.

North America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)

North America Cardiopulmonary Oxygenator Market Segmentation

The North America Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.

Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.

Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.

Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.

Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.

Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.

Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Cardiopulmonary Oxygenator market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in North America Cardiopulmonary Oxygenator market, thereby allowing players across the value chain to develop effective long-term strategies
  • develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Cardiopulmonary Oxygenator market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Cardiopulmonary Oxygenator Market - by Product
    • 1.3.2 North America Cardiopulmonary Oxygenator Market - by Application
    • 1.3.3 North America Cardiopulmonary Oxygenator Market - by Type
    • 1.3.4 North America Cardiopulmonary Oxygenator Market - by Age Group
    • 1.3.5 North America Cardiopulmonary Oxygenator Market - by End Use
    • 1.3.6 North America Cardiopulmonary Oxygenator Market - by Country

2. North America Cardiopulmonary Oxygenator Market Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Cardiopulmonary Oxygenator Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

Expert's Opinion

5. North America Cardiopulmonary Oxygenators Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Incidence of Cardiopulmonary Diseases
    • 5.1.2 Increasing Surgical Procedures with Surging in Aging Population
  • 5.2 Market Restraints
    • 5.2.1 Lack of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
  • 5.4 Future Trends
    • 5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
  • 5.5 Impact Analysis

6. Cardiopulmonary Oxygenators Market - North America Analysis

  • 6.1 North America Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis

7. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Membrane Oxygenator
    • 7.3.1 Overview
    • 7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Bubble Oxygenator
    • 7.4.1 Overview
    • 7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application

  • 8.1 Overview
  • 8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
  • 8.3 Cardiac
    • 8.3.1 Overview
    • 8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.3 Acute myocardial infarction
    • 8.3.4 Overview
    • 8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.6 Myocarditis
    • 8.3.7 Overview
    • 8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.9 Post-transplant complication
    • 8.3.10 Overview
    • 8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.12 Decompensated Cardiomyopathy
    • 8.3.13 Overview
    • 8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.3.15 Others
    • 8.3.16 Overview
    • 8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Respiratory
    • 8.4.1 Overview
    • 8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.3 Respiratory Failure
    • 8.4.4 Overview
    • 8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.6 Acute Respiratory Distress Syndrome
    • 8.4.7 Overview
    • 8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.9 Pulmonary Embolism
    • 8.4.10 Overview
    • 8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.12 Pneumonia
    • 8.4.13 Overview
    • 8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4.15 COVID-19
    • 8.4.16 Overview
    • 8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type

  • 9.1 Overview
  • 9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
  • 9.3 Reusable Oxygenator
    • 9.3.1 Overview
    • 9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Disposable Oxygenator
    • 9.4.1 Overview
    • 9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group

  • 10.1 Overview
  • 10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
  • 10.3 Adults
    • 10.3.1 Overview
    • 10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Pediatric
    • 10.4.1 Overview
    • 10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Neonates
    • 10.5.1 Overview
    • 10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use

  • 11.1 Overview
  • 11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
  • 11.3 Hospitals and Clinics
    • 11.3.1 Overview
    • 11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Ambulatory Surgical Centers
    • 11.4.1 Overview
    • 11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)

12. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis

  • 12.1 North America: Cardiopulmonary Oxygenators Market
    • 12.1.1 Overview
    • 12.1.3 North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
      • 12.1.3.1 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.1.1 Overview
        • 12.1.3.1.2 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.1.3 United States: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.1.4 United States: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.1.4.1 United States: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.1.4.2 United States: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.1.5 United States: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.1.6 United States: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.1.7 United States: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
      • 12.1.3.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.2.1 Overview
        • 12.1.3.2.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.2.3 Canada: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.2.4 Canada: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.2.4.1 Canada: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.2.4.2 Canada: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.2.5 Canada: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.2.6 Canada: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.2.7 Canada: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
      • 12.1.3.3 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.3.1 Overview
        • 12.1.3.3.2 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
        • 12.1.3.3.3 Mexico: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
        • 12.1.3.3.4 Mexico: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
        • 12.1.3.3.4.1 Mexico: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
        • 12.1.3.3.4.2 Mexico: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
        • 12.1.3.3.5 Mexico: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
        • 12.1.3.3.6 Mexico: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
        • 12.1.3.3.7 Mexico: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)

13. North America Cardiopulmonary Oxygenators Market-Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Getinge AB
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 LivaNova Plc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Medtronic Plc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Terumo Corp
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Nipro Medical Corp
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 MicroPort Scientific Corp
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Braile Biomedica Industry, Commerce and Representations Ltd
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
  • 14.8 Chalice Medical Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Fresenius Medical Care AG & Co KGaA
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms